Revolutionising allergies diagnostics with the next generation of ultra-sensitive highly multiplexed diagnostic tests based on micro-pearls

The WHO predicts that half of the European population will suffer from allergies.

Allergies are a growing burden for our society, our healthcare system and companies that have to take staff off work due to disabling symptoms.Thanks to fluorescent µpearls and the discovery of Quantum Plates, Nexdot is developing a highly multiplexed diagnostic test that will allow to assay IgE on 500 allergens (and up to 1000) at once using only one drop of blood.

This innovation will revolutionize the way allergies are treated by reducing drastically the time to diagnostic and its associated cost (x10-20 reduction).Our technology could also be extended to serology tests, for detection of patient’s antibodies against infectious agents or cancer markers.

It can be extended for global health for the easy and cost-effective detection of antigens as infectious or toxic agents in human, animals or environment for global health, or food for industry.